Table 2.
PCA (n = 25) | TEA (n = 25) | P-value | |
---|---|---|---|
Pain rest | |||
NRS POD1 | 3.00 (0–7) | 1.00 (0–7) | .09 |
NRS POD3 | 3.00 (0–10) | 2.00 (0–8) | .42 |
NRS POD7 | 1.50 (0–7) | 1.00 (0–4) | .041 |
Pain elevation arm | |||
NRS POD1 | 4.00 (0–10) | 2.00 (0–10) | .03 |
NRS POD3 | 4.00 (0–10) | 2.00 (0–8) | .14 |
NRS POD7 | 1.00 (0–7) | 1.00 (0–4) | .12 |
Pain mobilization bed side | |||
NRS POD1 | 4.50 (1–10) | 2.00 (0–9) | .1 |
NRS POD3 | 3.00 (1–10) | 2.00 (0–8) | .24 |
NRS POD7 | 1.00 (0–7) | 1.00 (0–4) | .09 |
Pain deep inspiration | |||
NRS POD1 | 5.00 (1–8) | 4.00 (0–9) | .04 |
NRS POD3 | 4.50 (1–10) | 3.00 (0–9) | .11 |
NRS POD7 | 2.50 (0–7) | 1.00 (0–5) | .014 |
FEV1 (l/s) | |||
POD1 | 1.16 | 1.05 | .81 |
POD3 | 1.14 | 1.29 | .47 |
POD7 | 1.65 | 1.92 | .1 |
Bupivacaine 0.125% in ml cumulative | |||
POD1 | 176 (84–371) | ||
POD3 | 521 (176–889) | ||
POD7 | 569 (176–1518) | ||
Piritramide iv in mg cumulative | |||
POD1 | 32 (3–70) | 0 (0–22) | |
POD3 | 39.25 (3–168) | 0 (0–110) | |
POD7 | 39.25 (3–324) | 0 (0–225) | |
Piritramide sc in mg cumulative | |||
POD1 | 0 (0–15) | 0 (0–15) | |
POD3 | 0 (0–15) | 0 (0–45) | |
POD7 | 0 (0–45) | 15 (0–112.5) | |
Metamizole iv [n (%)] | |||
POD1 | 23 (92) | 19 (76) | .12 |
POD3 | 23 (92) | 15 (60) | .008 |
POD7 | 16 (64) | 13 (54) | .48 |
Side effects [n (%)] | |||
Sedation | 0 | 0 | |
Nausea/Vomiting | 0 | 0 | |
Motor blockade | 1 (4) | ||
Catheter displacement | 4 (16) | ||
Use of rescue medication | 4 (16) | 4 (16) | |
Altered analgesia (TEA → PCA) | 3 (12) |
Table 2: Data are presented as median (min – max). PCA = patient-controlled analgesia, TEA = thoracic epidural analgesia, NRS = numeric rating scale, POD = postoperative day, FEV1 = forced expiratory volume in 1 s.